Achieving the AIDS Vaccine Goal: Recommendations from the Presidential Advisory Council on HIV and AIDS (Draft)

Draft #11 10/29/97 P. 11 of 13

APPENDIX C: REFERENCE DOCUMENTATION
AIDS Vaccine Advocacy Coalition (AVAC). Industry investment in HIV vaccine research.
December, 1996. (www.vactup.org/avac/contents.html).
AIDS Vaccine Development Policy & Issues.
(hsph.harvard.edu/organizations/hai/vaccines/preamble.html)
Avrett, S. (1997). AIDS vaccine. Healthlink, Aug/Sept, 6-7.
Cohen, Jon. (1995). Thailand weighs AIDS vaccine tests. Science, 270, 904-907.
Collins, Chris. (1997). Industry investment in HIV vaccine research.
SIDAlerte Quarterly TB & HIV, 14, May, 13, 19, 20.
Harvard AIDS Institute. HIV vaccines for developing countries: designing efficacy trials.
07/28/97. (www.hsph.harvard.edu/organi...cines/designing efficacytrials.html).
Esparza, J., Heyward, W. L., & Osmanov, S, (1996). HIV Vaccine Development: From basic
research to human trials. AIDS, 10 (suppl A), s123-s132.
Fast, P. E., Mathieson, B. J., Schultz, A.M. (1994). Efficacy trials of AIDS vaccines: How
science can inform ethics. Current Opinion in Immunology, 6, 691-697.
Francis, D. P., & Kennedy, D. (1994). A private-sector AIDS vaccine? Don't hold your breath.
(Op-ed), The Washington Post, (July 19).
Francis, D. P. (1995). Why AIDS vaccine development is taking longer than it should. Current
Issues in Public Health, 1, 181-185.
Green, J. (1995). Who put the lid on gpl20? The New York Times Magazine, March 26, 50 -57, 74, 82.
Heyward, W. L. MacQueen, K. M., & Jaffe, H. W. (1997). Obstacles and progress toward
development of a preventive HIV vaccine. Journal of the International Association of Physicians
in AIDS Care, 3, 28-34.
Mahoney, R. T. (1996). Developing vaccines against HIV: Options for accelerated progress.
AIDS & Public Policy Journal, 11, 28-35.
Mascola, J. R., McNeil, J. G., Burke, D. S. (1994). AIDS vaccines: Are we ready for human
efficacy trials? JAMA, 272, 488-489.